Search Articles
PHILADELPHIA – Indirect purchasers of the once-a-day Wellbutrin XL antidepressant won class certification for a federal lawsuit accusing Biovail, SmithKline Beecham and other companies of illegally conspiring to prevent generic versions from entering the American market.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.